Expertise in
2
conditions

Dr. Jordan E. Pinsker

Pediatric Endocrinology
2219 Bath Street, William Sansum Diabetes Center, 
Santa Barbara, CA 
Expertise in
2
conditions
2219 Bath Street, William Sansum Diabetes Center, 
Santa Barbara, CA 

Overview

Jordan Pinsker is a Pediatric Endocrinologist in Santa Barbara, California. Dr. Pinsker is highly rated in 2 conditions, according to our data. His top areas of expertise are Type 1 Diabetes (T1D), Low Blood Sugar, Diabetic Ketoacidosis, and Type 2 Diabetes (T2D).

His clinical research consists of co-authoring 105 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Pediatric Endocrinology

Licenses

Pediatric Endocrinology in CA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

2219 Bath Street, William Sansum Diabetes Center, Santa Barbara, CA 93105

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

Multi-center, Randomized, Parallel, Adaptive, Controlled Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control (CSII, MDI and SAP) at Home
Multi-center, Randomized, Parallel, Adaptive, Controlled Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control (CSII, MDI and SAP) at Home
Enrollment Status: Completed
Publish Date: August 19, 2025
Intervention Type: Device
Study Phase: Not Applicable
Tandem PLGS Pivotal Trial: A Randomized Clinical Trial to Assess the Efficacy of Predictive Low Glucose Suspend Versus Sensor-augmented Pump Therapy in the Management of Type 1 Diabetes
Tandem PLGS Pivotal Trial: A Randomized Clinical Trial to Assess the Efficacy of Predictive Low Glucose Suspend Versus Sensor-augmented Pump Therapy in the Management of Type 1 Diabetes
Enrollment Status: Completed
Publish Date: December 08, 2023
Intervention Type: Device
Study Phase: Not Applicable
Supervised Safety and Feasibility Evaluation of the Zone-MPC Control Algorithm Integrated Into the iAPS in Pregnant Patients With Type 1 Diabetes With Extension Into Outpatient at Home
Supervised Safety and Feasibility Evaluation of the Zone-MPC Control Algorithm Integrated Into the iAPS in Pregnant Patients With Type 1 Diabetes With Extension Into Outpatient at Home
Enrollment Status: Completed
Publish Date: August 04, 2023
Intervention Type: Device
Study Phase: Not Applicable
Clinical Acceptance of the Artificial Pancreas: the International Diabetes Closed Loop (iDCL) Trial: A Randomized Clinical Trial to Assess the Efficacy of Adjunctive Closed Loop Control Versus Sensor-Augmented Pump Therapy in the Management of Type 1 Diabetes
Clinical Acceptance of the Artificial Pancreas: the International Diabetes Closed Loop (iDCL) Trial: A Randomized Clinical Trial to Assess the Efficacy of Adjunctive Closed Loop Control Versus Sensor-Augmented Pump Therapy in the Management of Type 1 Diabetes
Enrollment Status: Completed
Publish Date: December 05, 2022
Intervention Type: Other, Device
Study Phase: Not Applicable
The International Diabetes Closed Loop (iDCL) Trial: A Randomized Crossover Comparison of Adaptive Model Predictive Control (MPC) Artificial Pancreas Versus Sensor Augmented Pump (SAP)/Predictive Low Glucose Suspend (PLGS) in the Outpatient Setting in Type 1 Diabetes (DCLP4)
The International Diabetes Closed Loop (iDCL) Trial: A Randomized Crossover Comparison of Adaptive Model Predictive Control (MPC) Artificial Pancreas Versus Sensor Augmented Pump (SAP)/Predictive Low Glucose Suspend (PLGS) in the Outpatient Setting in Type 1 Diabetes (DCLP4)
Enrollment Status: Completed
Publish Date: December 02, 2022
Intervention Type: Device, Other
Study Phase: Not Applicable
A Randomized Crossover Comparison of Artificial Pancreas vs. Sensor Augmented Pump/Predictive Low Glucose Suspend With Different Stress Assessments in the Outpatient Setting for Patients With Type 1 Diabetes
A Randomized Crossover Comparison of Artificial Pancreas vs. Sensor Augmented Pump/Predictive Low Glucose Suspend With Different Stress Assessments in the Outpatient Setting for Patients With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: December 01, 2020
Intervention Type: Other, Device
Study Phase: Not Applicable
A Pivotal Study of t:Slim X2 With Control-IQ Technology
A Pivotal Study of t:Slim X2 With Control-IQ Technology
Enrollment Status: Completed
Publish Date: April 28, 2020
Intervention Type: Device
Study Phase: Not Applicable
A Randomized Crossover Comparison of Model Predictive Control (MPC) Artificial Pancreas vs. Sensor Augmented Pump (SAP)/Predictive Low Glucose Suspend (PLGS) With Different Food Choices in the Outpatient Setting
A Randomized Crossover Comparison of Model Predictive Control (MPC) Artificial Pancreas vs. Sensor Augmented Pump (SAP)/Predictive Low Glucose Suspend (PLGS) With Different Food Choices in the Outpatient Setting
Enrollment Status: Completed
Publish Date: August 08, 2019
Intervention Type: Device
Study Phase: Not Applicable
An Early Feasibility Study to Evaluate the Predictive Low Glucose Suspend Functionality and Safety in an Automated Insulin Delivery System in Adult Patients With Type 1 Diabetes Mellitus
An Early Feasibility Study to Evaluate the Predictive Low Glucose Suspend Functionality and Safety in an Automated Insulin Delivery System in Adult Patients With Type 1 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: June 05, 2019
Intervention Type: Device, Drug
Study Phase: Not Applicable
Inpatient Safety and Feasibility Evaluation of the Zone-MPC Control Algorithm Integrated Into the APS APP
Inpatient Safety and Feasibility Evaluation of the Zone-MPC Control Algorithm Integrated Into the APS APP
Enrollment Status: Completed
Publish Date: September 05, 2018
Intervention Type: Device
Study Phase: Phase 2/Phase 3
A Clinical Study to Investigate and Compare the Impact of High Protein Pasta, Lower Protein Pasta and White Rice on Blood Sugar Control in People With Type 1 Diabetes Mellitus (T1DM)
A Clinical Study to Investigate and Compare the Impact of High Protein Pasta, Lower Protein Pasta and White Rice on Blood Sugar Control in People With Type 1 Diabetes Mellitus (T1DM)
Enrollment Status: Completed
Publish Date: September 05, 2018
Intervention Type: Other
Study Phase: Not Applicable
Feasibility Study Using Run-to-Run Control to Optimize Continuous Glucose Sensor Bias
Feasibility Study Using Run-to-Run Control to Optimize Continuous Glucose Sensor Bias
Enrollment Status: Completed
Publish Date: July 12, 2018
Intervention Type: Device
Clinical Acceptance of the Artificial Pancreas: the International Diabetes Closed Loop (iDCL) Trial Research Site Training Protocol
Clinical Acceptance of the Artificial Pancreas: the International Diabetes Closed Loop (iDCL) Trial Research Site Training Protocol
Enrollment Status: Completed
Publish Date: May 07, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 12 Less Clinical Trials

105 Total Publications

Consistent Benefit of Control-IQ+ Automated Insulin Delivery Across a Range of Characteristics of Adults with Type 2 Diabetes.
Consistent Benefit of Control-IQ+ Automated Insulin Delivery Across a Range of Characteristics of Adults with Type 2 Diabetes.
Journal: Diabetes technology & therapeutics
Published: January 23, 2026
Similar Doctors
Expertise in
0
conditions
Dr. Christopher Ferber
Pediatric Endocrinology
Expertise in
0
conditions
Dr. Christopher Ferber
Pediatric Endocrinology

Grotenhuis Pediatric Clinic

5333 Hollister Ave Ste 250, 
Santa Barbara, CA 
 (4.9 miles away)
805-879-4240
Languages Spoken:
English
See accepted insurances

Christopher Ferber is a Pediatric Endocrinologist in Santa Barbara, California. His top areas of expertise are Short Stature (Growth Disorders), Idiopathic Short Stature (ISS), Familial Short Stature (FSS), and Precocious Puberty.

Expertise in
0
conditions
Dr. Fima Lifshitz
Pediatric Endocrinology
Expertise in
0
conditions
Dr. Fima Lifshitz
Pediatric Endocrinology

California Neurological Inst

2219 Bath St Fl 1, 
Santa Barbara, CA 
 (8.2 miles away)
805-565-0370
Languages Spoken:
English
See accepted insurances

Fima Lifshitz is a Pediatric Endocrinologist in Santa Barbara, California. His top areas of expertise are Periodontitis, Obesity in Children, Congenital Hyperinsulinism, and Obesity.

Expertise in
0
conditions
Dr. Zohreh Shoar
Pediatric Endocrinology
Expertise in
0
conditions
Dr. Zohreh Shoar
Pediatric Endocrinology

Grotenhuis Pediatric Clinic

5333 Hollister Ave Ste 250, 
Santa Barbara, CA 
 (4.9 miles away)
805-879-4240
Languages Spoken:
English
See accepted insurances

Zohreh Shoar is a Pediatric Endocrinologist in Santa Barbara, California. Her top areas of expertise are Precocious Puberty, Short Stature (Growth Disorders), Idiopathic Short Stature (ISS), and Familial Short Stature (FSS).

Frequently Asked Questions about Dr. Jordan E. Pinsker

How do I make an appointment with Dr. Jordan E. Pinsker?

You can book an appointment with Dr. Jordan E. Pinsker by calling their office at 805-682-7640. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jordan E. Pinsker a top-rated expert for Type 1 Diabetes (T1D)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jordan E. Pinsker is classified as an Elite expert for Type 1 Diabetes (T1D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jordan E. Pinsker specialize in?

While Dr. Jordan E. Pinsker is a Pediatric Endocrinology, they have specific expertise in Type 1 Diabetes (T1D), Low Blood Sugar, and Diabetic Ketoacidosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Endocrinology.

Does Dr. Jordan E. Pinsker participate in research or clinical trials?

Yes. Dr. Jordan E. Pinsker has published 105 articles and abstracts on conditions like Type 1 Diabetes (T1D). You can view a list of Dr. Jordan E. Pinsker's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jordan E. Pinsker accept my insurance?

Dr. Jordan E. Pinsker accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 805-682-7640 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Pinsker's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile